Meeting on the Med 2022

Treating otoferlin deficiency with gene therapy 2:51
Treating otoferlin deficiency with gene therapy
Nawal Ouzren • 26 Apr 2022
Novel gene therapy solutions for Usher syndrome type I 2:05
Novel gene therapy solutions for Usher syndrome type I
Nawal Ouzren • 26 Apr 2022
Developing gene therapies for GJB2 gene related hearing loss 1:59
Developing gene therapies for GJB2 gene related hearing loss
Nawal Ouzren • 26 Apr 2022
CYP-001 in adults with steroid-resistant GvHD 3:00
CYP-001 in adults with steroid-resistant GvHD
Ross Macdonald • 19 Apr 2022
SCUlpTOR: CYP-004 in osteoarthritis 2:56
SCUlpTOR: CYP-004 in osteoarthritis
Ross Macdonald • 19 Apr 2022
Plasmacytoid dendritic cell-based cancer vaccines 1:43
Plasmacytoid dendritic cell-based cancer vaccines
Eric Halioua • 20 Apr 2022
Developing a therapeutic cancer vaccine for patients with NSCLC 2:41
Developing a therapeutic cancer vaccine for patients with NSCLC
Eric Halioua • 20 Apr 2022
Assessing PDC*mel, dendritic cell-based vaccine in melanoma 1:34
Assessing PDC*mel, dendritic cell-based vaccine in melanoma
Eric Halioua • 20 Apr 2022
Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
Generating iSPC-derived MSCs with the Cymerus™ Platform 2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
The future of omentum-based autologous tissue engineering 1:01
The future of omentum-based autologous tissue engineering
Asaf Toker • 19 Apr 2022
Autologous tissue-engineered solutions for spinal cord injuries 2:36
Autologous tissue-engineered solutions for spinal cord injuries
Asaf Toker • 19 Apr 2022
Restoring cardiac tissue with omentum-based hydrogel implants 1:35
Restoring cardiac tissue with omentum-based hydrogel implants
Asaf Toker • 19 Apr 2022
The content of VJRegenMed is intended for healthcare professionals